Show simple item record

dc.contributor.authorGregersen, Peter K.
dc.contributor.authorGravallese, Ellen M.
dc.date2022-08-11T08:09:51.000
dc.date.accessioned2022-08-23T16:46:07Z
dc.date.available2022-08-23T16:46:07Z
dc.date.issued2018-10-20
dc.date.submitted2018-11-29
dc.identifier.citation<p>N Engl J Med. 2018 Oct 20. doi: 10.1056/NEJMe1811767. [Epub ahead of print] <a href="https://doi.org/10.1056/NEJMe1811767">Link to article on publisher's site</a></p>
dc.identifier.issn0028-4793 (Linking)
dc.identifier.doi10.1056/NEJMe1811767
dc.identifier.pmid30345908
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40817
dc.description.abstractClinical heterogeneity is a hallmark of many autoimmune disorders, and clinical or subclinical pulmonary involvement is a common extraarticular feature of the rheumatoid arthritis (RA) phenotype. High-resolution computed tomography reveals evidence of pulmonary abnormalities in more than half of patients with RA, and clinically significant interstitial lung disease (ILD) will develop in approximately 10% of patients.It is currently difficult to identify these patients and to intervene early in the clinical course of their lung disease.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30345908&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © 2018 Massachusetts Medical Society. Publisher PDF posted after 6 months as allowed by publisher's Author Permissions policy at: https://www.nejm.org/author-center/permissions.
dc.subjectpulmonary
dc.subjectrheumatoid arthritis
dc.subjectinterstitial lung disease
dc.subjectDiagnosis
dc.subjectImmune System Diseases
dc.subjectMusculoskeletal Diseases
dc.subjectPulmonology
dc.subjectRespiratory Tract Diseases
dc.subjectRheumatology
dc.subjectSkin and Connective Tissue Diseases
dc.titleBreathing New Life into Interstitial Lung Disease in Rheumatoid Arthritis
dc.typeEditorial
dc.source.journaltitleThe New England journal of medicine
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4636&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3624
dc.legacy.embargo2019-03-20T00:00:00-07:00
dc.identifier.contextkey13391896
refterms.dateFOA2022-08-23T16:46:07Z
html.description.abstract<p>Clinical heterogeneity is a hallmark of many autoimmune disorders, and clinical or subclinical pulmonary involvement is a common extraarticular feature of the rheumatoid arthritis (RA) phenotype. High-resolution computed tomography reveals evidence of pulmonary abnormalities in more than half of patients with RA, and clinically significant interstitial lung disease (ILD) will develop in approximately 10% of patients.It is currently difficult to identify these patients and to intervene early in the clinical course of their lung disease.</p>
dc.identifier.submissionpathoapubs/3624
dc.contributor.departmentDepartment of Medicine, Division of Rheumatology


Files in this item

Thumbnail
Name:
nejme1811767.pdf
Size:
105.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record